EPIRUS Biopharmaceuticals, Inc. Operating Cash Flow
EPIRUS Biopharmaceuticals, Inc. reported Operating Cash Flow of -$5.22 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2014-05-09
- EPIRUS Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2014-03-31 was -$5.22M.
- EPIRUS Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2013-12-31 was -$6.20M.
- EPIRUS Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2013-09-30 was -$8.12M.
- EPIRUS Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2013-06-30 was -$6.70M.
- EPIRUS Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2013 was -$29.73M.
- EPIRUS Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2012 was -$38.49M.
- EPIRUS Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2011 was -$33.38M, a 278.69% decline from fiscal 2010.
- EPIRUS Biopharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2010 was $18.68M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2014-03-31 | -$5.22M 10-Q · filed 2014-05-09 | -$11.42M derived: sum of 2 quarters · filed 2014-05-09 | -$19.54M derived: sum of 3 quarters · filed 2014-05-09 | -$26.24M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | -$6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$14.32M derived: sum of 2 quarters · filed 2014-03-14 | -$21.02M derived: sum of 3 quarters · filed 2014-03-14 | -$29.73M 10-K · filed 2014-03-14 |
| 2013-09-30 | -$8.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | -$14.82M derived: sum of 2 quarters · filed 2013-11-04 | -$23.54M 10-Q · filed 2013-11-04 | -$30.63M derived: sum of 4 quarters · filed 2014-03-14 |
| 2013-06-30 | -$6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | -$15.42M 10-Q · filed 2013-08-05 | -$22.51M derived: sum of 3 quarters · filed 2014-03-14 | -$31.89M derived: sum of 4 quarters · filed 2014-03-14 |
| 2013-03-31 | -$8.71M 10-Q · filed 2014-05-09 | -$15.81M derived: sum of 2 quarters · filed 2014-03-14 | -$25.18M derived: sum of 3 quarters · filed 2014-03-14 | -$36.12M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-12-31 | -$7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$16.47M derived: sum of 2 quarters · filed 2014-03-14 | -$27.40M derived: sum of 3 quarters · filed 2014-03-14 | -$38.49M 10-K · filed 2014-03-14 |
| 2012-09-30 | -$9.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | -$20.31M derived: sum of 2 quarters · filed 2013-11-04 | -$31.40M 10-Q · filed 2013-11-04 | -$38.90M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | -$10.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | -$22.02M 10-Q · filed 2013-08-05 | -$29.52M derived: sum of 3 quarters · filed 2014-03-14 | -$36.36M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | -$11.09M 10-Q · filed 2013-05-03 | -$18.59M derived: sum of 2 quarters · filed 2014-03-14 | -$25.43M derived: sum of 3 quarters · filed 2014-03-14 | -$35.15M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | -$7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$14.34M derived: sum of 2 quarters · filed 2014-03-14 | -$24.06M derived: sum of 3 quarters · filed 2014-03-14 | -$33.38M 10-K · filed 2014-03-14 |
| 2011-09-30 | -$6.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$16.56M derived: sum of 2 quarters · filed 2012-11-08 | -$25.88M 10-Q · filed 2012-11-08 | -$30.36M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | -$9.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$19.03M 10-Q · filed 2012-08-07 | -$23.52M derived: sum of 3 quarters · filed 2013-03-07 | -$27.09M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | -$9.32M 10-Q · filed 2012-05-04 | -$13.80M derived: sum of 2 quarters · filed 2013-03-07 | -$17.37M derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | -$4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | -$8.06M derived: sum of 2 quarters · filed 2013-03-07 | $18.68M 10-K · filed 2013-03-07 | |
| 2010-09-30 | -$3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $23.17M 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $26.73M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$24.99M 10-K · filed 2012-03-09 |